微芯生物(688321.SH)：上半年净利润2959.22万元，同比实现扭亏为盈

Core Insights - Microchip Biotech (688321.SH) reported a revenue of 407 million yuan for the first half of 2025, representing a year-on-year growth of 34.56% [1] - The net profit attributable to shareholders of the listed company was 29.59 million yuan, marking a turnaround from a loss to profit compared to the previous year [1] - The net profit excluding non-recurring gains and losses was 20.32 million yuan, with a basic earnings per share of 0.0726 yuan [1] Revenue Growth - The significant revenue increase of 34.56% was primarily driven by the sales growth of Sidabone and Siglitazone [1]